| Literature DB >> 33348039 |
Stacy L Pineles1, Michael X Repka2, Fei Yu3, Federico G Velez4, Claudia Perez5, Danielle Sim5, Anne L Coleman6.
Abstract
Atropine and patching are standard treatments for amblyopia, but the prevalence of atropine therapy in the United States is unknown. This study used the OptumLabs Data Warehouse to evaluate pharmacy claims for topical atropine to evaluate the frequency of its treatment for amblyopia and to compare demographic factors in cohorts of amblyopic children who were and were not prescribed atropine. Overall, 55.2% of amblyopic children were prescribed atropine more than once. The children who were prescribed atropine had a higher likelihood of living in geographic regions in the South or Midwest.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33348039 PMCID: PMC9037612 DOI: 10.1016/j.jaapos.2020.11.003
Source DB: PubMed Journal: J AAPOS ISSN: 1091-8531 Impact factor: 1.220